HFX AdaptivAI combines insights from more than 100 million data points and more than 100,000 patients for responsive and personalized pain relief, according to a news release. The spinal cord stimulator provides real-time insights and remote monitoring for physicians.
Nevro plans a full U.S. market release of HFX iQ with HFX AdaptiveAI in the fourth quarter of 2024.
